Tag: BioSTL

SentiAR Announces FDA 510K Clearance of CommandEP™ System, the First Holographic Cardiac Ablation Guidance System

ST. LOUIS, Sept. 30, 2020 /PRNewswire/ — SentiAR, a pioneer in visualization technologies for surgical applications announces U.S. Food and Drug Administration (FDA) 510(k) clearance of its groundbreaking CommandEP™ system, the first holographic guidance system to be used during an invasive cardiac procedure. The CommandEP system allows electrophysiologists to visualize 3D electroanatomic models in […]